XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

August 31, 2029

Study Completion Date

August 31, 2030

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL

XH001

mRNA neoantigen cancer vaccine

DRUG

Chemotherapy

Gemcitabine+Capecitabine or Oxaliplatin+lrinotecan+Calcium folinate+5-FU

Trial Locations (1)

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER